Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
ANAB
#2214
AnaptysBio, Inc. - Common Stock
46.0
4
USD
0.00%
Market Price
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
+0.20%
Monthly Change
-15.63%
6 month change
-33.28%
Year Change
+30.80%
Previous Close
45.9
5
Open
46.1
6
Low
45.9
9
High
46.7
8
Markets
US Stock Market
Healthcare
Biotechnology
ANAB
1D
1W
1M
3M
6M
YTD
1Y
5Y
Open full chart
Financials
Overview
Statement
Statistics
Documents
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
Current
Key stats
Total common shares outstanding
27.37 M
27.67 M
27.93 M
26.76 M
30.67 M
28.75 M
29.1 M
Valuation ratios
Enterprise value
337.92 M
465.89 M
744.84 M
544.79 M
282.95 M
1.16 B
1.14 B
Price to earnings ratio
—
-16.47
-6.39
-3.57
-2.59
-105.39
-46.83
Price to sales ratio
—
15.09
80
34.05
4.12
5.94
5.93
Price to cash flow ratio
—
-20.76
-11.18
-4.84
-2.78
70.78
290.09
Price to book ratio
—
2.67
3.14
6.63
5.3
37.47
-57.67
Enterprise value to EBITDA ratio
-14.49
-8.29
-6.51
-3.33
-2.47
23.85
27.61
Profitability ratios
Return on assets %
-0.05
-0.09
-0.21
-0.36
-0.3
-0.04
-0.16
Return on equity %
-0.05
-0.16
-0.49
-1.86
-2.05
-0.36
-4.15
Return on invested capital %
-238.66
-409.35
-360.47
-619.98
-899
1 195.61
-868.75
Gross margin %
100
100
100
100
100
100
100
Operating margin %
-31.84
-89.93
-1 119.41
-958.27
-125.93
20.42
-135.53
EBITDA margin %
-31.09
-88.95
-1 112.85
-954.47
-125.27
20.65
-135.03
Net margin %
-26.57
-91.49
-1 251.33
-953.66
-159.1
-5.64
-206.93
Liquidity ratios
Quick ratio
—
—
—
—
—
—
—
Current ratio
20.01
34.4
17.16
10.87
9.51
9.07
7.58
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
0.18
0.12
0.02
0.03
0.19
0.64
0.07
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
0
—
—
—
—
—
—
Long term debt to total equity ratio
0
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
—
-1.67
-2.61
-4.49
-4.77
0.68
0.16
EBIT per share
—
-2.07
-4.09
-6.11
-4.05
1.67
1.41
EBITDA per share
—
-2.05
-4.06
-6.08
-4.03
1.68
1.43
Total debt per share
—
—
—
—
—
—
—
Cash per share
—
19.98
15.67
14.52
13.58
10.84
9.98
Net current asset value per share
—
20.19
15.88
15.11
15.22
12.18
11.02
Tangible book value per share
—
12.99
9.31
3.27
2.5
1.29
0.44
Working capital per share
—
19.6
14.95
13.72
13.62
10.84
9.56
Book value per share
—
12.99
9.31
3.27
2.5
1.29
0.44
News
Why This IPO Stock, An AnaptysBio Spinoff, Just Skyrocketed
JP Morgan Maintains Overweight on AnaptysBio, Lowers Price Target to $60
HC Wainwright & Co. Reiterates Buy on AnaptysBio, Maintains $95 Price Target
Leerink Partners Maintains Outperform on AnaptysBio, Lowers Price Target to $81
AnaptysBio, Inc. (ANAB) Reports Q2 Loss, Tops Revenue Estimates
12 Health Care Stocks Moving In Monday's After-Market Session
AnaptysBio Q2 Adj. EPS $(0.11) Beats $(0.46) Estimate, Sales $27.488M Beat $21.675M Estimate
GSK's sBLA for Jemperli Gets FDA Priority Tag in Rectal Cancer
AnaptysBio Stock: The Royalty Waterfall Is About To Reverse (NASDAQ:ANAB)
GSK's Jemperli Delivers Promising Interim Data in Rectal Cancer
Nvidia Releases First Full-Stack Safety System for Robot 'Physical AI' Halos for Robotics
Is AnaptysBio (ANAB) Outperforming Other Medical Stocks This Year?